Abpro Corporation

ABPNASDAQHealthcare

$0.52

+$0.00(+0.00%)

Market Cap$1057699

P/E Ratio—

52W High$18.03

52W Low$0.11

Avg Volume1.7M

Open$0.76

Beta-0.00

Free Cash Flow Financials Revenue

Abpro Corporation (ABP) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ABP · free cash flow · updated Jun 9, 2026

Core FCF metrics

ABP · FCF · TTM · margin & CAGR

Free cash flow was −$9.0M for FY2024 (fiscal year ending 2024-12-31), down 21.2% year-over-year

FY2024 Free Cash Flow−$9.0M▼ -21.2% YoY

Trailing 12M (TTM)−$13.6Mtrailing 4 quarters sum

FCF Margin< −999%−$9.0M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

ABP · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2024Latest−$9.0M(0M)−$9.0M▼ 21.2%—

FY2023−$7.4M(0M)−$7.5M▲ +17.4%—

FY2022−$9.0M(0M)−$9.0M▲ +17.8%-444.4%

FY2021−$11.0M(0M)−$11.0M▼ 7.1%—

FY2017−$9.5M(1M)−$10.2M▼ 105.2%-465.0%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

ABP · P/FCF · FCF yield · FCF per share

Abpro Corporation (ABP) reported negative free cash flow of −$0.01B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-12-31

Cash flow statement summary

ABP · cash flow statement · operating / investing / financing

For FY2024, Abpro Corporation generated −$9.0M in operating cash flow and spent 0M in capital expenditures, yielding −$9.0M in free cash flow.

Operating Activities

−$9.0M

Cash from core business operations

2024-12-31

Investing Activities

+$0.0M

CapEx, acquisitions & investments

2024-12-31

Financing Activities

+$11.2M

Buybacks, dividends & debt

2024-12-31

FCF FormulaOperating CF (−$9.0M) − |CapEx| (0M) = FCF (−$9.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

ABP vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Abpro CorporationYOU

ABP

−$9.0M-21.2%-4934.4%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Abpro Corporation (ABP) reported free cash flow of −$9.0M for FY2024 (fiscal year ending 2024-12-31), down 21.2% year-over-year.

Abpro Corporation has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 6 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

ABP free cash flow · 8 questions

Abpro Corporation free cash flow was −$9.0M for FY2024, down 21.2% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$13.6M.

ABP free cash flowABP FCFABP FCF 2024ABP free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Abpro Corporation · Abpro Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026